Second Generation Antiretroviral Therapies
While the price for many antiretroviral therapies has plumeted over the last decade, the price of second generation antiretrovirals remains prohibitively high for many in the global South. These include second-line therapies, which usually include protease inhibitorsm and must be taken after a person taking antiretrovirals develops resistance to the first-line therapy. Additionally, second generation therapies include first-line therapies recommended by WHO that include newer, less toxic medicines.
PIJIP Documents
- Timeline on Brazil's Compulsory Licensing. (June 15, 2007).
- Promoting Access to Second Generation AIDS Treatment in the Second Decade After TRIPS. (June 5, 2007).
- The Second Wave of Developing Country Activism on AIDS Drug Pricing. (May 8, 2007).
Civil Society Documents
- July 23, 2007. Médecins Sans Frontières. Report Shows Up to 500 Percent Price Rise in HIV/AIDS drugs
- July 23, 2007. Médecins Sans Frontières. Untangling the Web of Price Reductions, 10th edition
- August, 2006. World Health Organization. Revised Guidelines for Antiretroviral Therapy for Adults and Adolescents
